Canakinumab (Anti-IL-1b)
Canakinumab (Anti-IL-1b) is a recombinant human anti-IL-1β monoclonal antibody targeting IL-1β and neutralizing IL-1β signaling. It can be used in treatment of disorders of autoimmune origin like familial mediterranean fever, mevalonate kinase deficiency, tumor necrosis factor receptor-associated periodic syndrome (TRAPS). MW :145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2446 |
Sku # | A2446-1mg*5 |
Pricing | 1mg*5, $1690.00 |